Ibrutinib in relapsed/refractory patients with Waldenström macroglobulinemia: a real-life, retrospective study on behalf of the “RTL” (regional Tuscan lymphoma network)

Emanuele Cencini, Ilaria Romano, Francesco Ghio, Chiara Camerini, Ilaria Bertaggia, Roberta Giachetti, Lara Mannelli, Maria Teresa Pirrotta, Giulia Lucco Navei, Manuel Ciceri, Giulia Cervetti, Emanuela Sant’Antonio, Federico Simonetti, Silvia Birtolo, Benedetta Puccini, Monica Bocchia, Alberto Fabbri

Open source

DOI: 10.1007/s00277-023-05113-9
Published: 2023-02-03
Container: Annals of Hematology
Publisher: Springer Science and Business Media LLC
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1007/s00277-023-05113-9,
  title = {Ibrutinib in relapsed/refractory patients with Waldenström macroglobulinemia: a real-life, retrospective study on behalf of the “RTL” (regional Tuscan lymphoma network)},
  author = {Emanuele Cencini and Ilaria Romano and Francesco Ghio and Chiara Camerini and Ilaria Bertaggia and Roberta Giachetti and Lara Mannelli and Maria Teresa Pirrotta and Giulia Lucco Navei and Manuel Ciceri and Giulia Cervetti and Emanuela Sant’Antonio and Federico Simonetti and Silvia Birtolo and Benedetta Puccini and Monica Bocchia and Alberto Fabbri},
  year = {2023},
  journal = {Annals of Hematology},
  doi = {10.1007/s00277-023-05113-9},
  url = {https://doi.org/10.1007/s00277-023-05113-9}
}

RIS

TY  - JOUR
TI  - Ibrutinib in relapsed/refractory patients with Waldenström macroglobulinemia: a real-life, retrospective study on behalf of the “RTL” (regional Tuscan lymphoma network)
AU  - Emanuele Cencini
AU  - Ilaria Romano
AU  - Francesco Ghio
AU  - Chiara Camerini
AU  - Ilaria Bertaggia
AU  - Roberta Giachetti
AU  - Lara Mannelli
AU  - Maria Teresa Pirrotta
AU  - Giulia Lucco Navei
AU  - Manuel Ciceri
AU  - Giulia Cervetti
AU  - Emanuela Sant’Antonio
AU  - Federico Simonetti
AU  - Silvia Birtolo
AU  - Benedetta Puccini
AU  - Monica Bocchia
AU  - Alberto Fabbri
PY  - 2023
JO  - Annals of Hematology
DO  - 10.1007/s00277-023-05113-9
UR  - https://doi.org/10.1007/s00277-023-05113-9
ER  -

APA

Cencini, E., Romano, I., Ghio, F., Camerini, C., Bertaggia, I., Giachetti, R., Mannelli, L., Pirrotta, M. T., Navei, G. L., Ciceri, M., Cervetti, G., Sant’Antonio, E., Simonetti, F., Birtolo, S., Puccini, B., Bocchia, M., & Fabbri, A. (2023). Ibrutinib in relapsed/refractory patients with Waldenström macroglobulinemia: a real-life, retrospective study on behalf of the “RTL” (regional Tuscan lymphoma network). Annals of Hematology. https://doi.org/10.1007/s00277-023-05113-9

Source records

crossref · retrieved 2026-09-26T20:49:16.870Z